OraSure Technologies Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by OraSure Technologies, Inc. on September 28, 2004. The report discloses two material events: an amendment to a credit facility and a significant development in ongoing patent litigation.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, or margin data for the period. However, it references the company's existing credit facilities:
- Total Credit Facilities: $10.9 million provided by Comerica Bank.
- Revolving Line of Credit: $4.0 million working capital line.
- Liquidity Update: The maturity date for the Revolving Line was extended from November 9, 2004, to April 30, 2005.
Material Changes
The primary material change reported is the extension of the maturity date for the company's $4.0 million revolving working capital line of credit. This change was effected via a Letter Agreement executed on September 27, 2004, between OraSure and Comerica Bank.
Outlook, Risks, and Contingencies
Legal Contingency: On September 28, 2004, the company announced that an expedited trial has been ordered in its patent infringement lawsuit against Schering-Plough Healthcare Products, Inc. This development represents a significant contingency that could impact future operations or financial results depending on the trial outcome.
Investor Verification Checklist
- Verify the terms of the Letter Agreement extending the credit facility maturity to April 30, 2005 (Exhibit 10).
- Review the press release regarding the expedited trial in the Schering-Plough patent infringement case (Exhibit 99).
- Assess the potential financial impact of the patent litigation outcome on the company's intellectual property portfolio and revenue streams.
- Confirm the current utilization status of the $4.0 million revolving line of credit.